Healthcare >> CEO Interviews >> October 12, 2001
JOHN W. JACKSON has been Chairman and Chief Executive Officer of Celgene
since January 1996. Prior to joining Celgene, Mr. Jackson held senior
positions with Merck and American Cyanamid. He holds a BA from Yale
University and an MBA from INSEAD, in France. He served as a U.S. Marine
infantry officer in Vietnam. Profile
TWST: Could we start out with a quick update on Celgene. I know we spokeearlier on in the year. What's gone on in the past couple of quarters
that investors should focus on?
Mr. Jackson: